HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Frank Porreca Selected Research

Hyperesthesia

9/20111,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.
8/2011Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Frank Porreca Research Topics

Disease

89Pain (Aches)
11/2015 - 01/2002
46Hyperalgesia
01/2015 - 05/2002
40Hypersensitivity (Allergy)
01/2016 - 06/2002
37Neuralgia (Stump Neuralgia)
05/2015 - 01/2002
12Migraine Disorders (Migraine)
11/2014 - 02/2009
11Inflammation
06/2012 - 10/2003
6Neoplasms (Cancer)
10/2015 - 06/2003
6Headache (Headaches)
02/2012 - 10/2008
3Tics (Tic)
04/2011 - 02/2003
3Pancreatitis
11/2010 - 06/2006
2Hyperesthesia
09/2011 - 08/2011
2Nervous System Diseases (Neurological Disorders)
08/2011 - 08/2010
2Spontaneous Fractures (Pathological Fracture)
01/2011 - 11/2007
2Wounds and Injuries (Trauma)
10/2005 - 06/2003
2Edema
06/2004 - 10/2003

Drug/Important Bio-Agent (IBA)

20Dynorphins (Dynorphin)IBA
01/2015 - 06/2002
19Morphine (MS Contin)FDA LinkGeneric
10/2015 - 08/2002
17Opioid Analgesics (Opioids)IBA
05/2015 - 06/2003
13Lidocaine (Xylocaine)FDA LinkGeneric
08/2013 - 06/2002
7LigandsIBA
11/2015 - 01/2005
7Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2013 - 12/2002
63- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)IBA
10/2015 - 01/2011
6Clonidine (ST 155)FDA LinkGeneric
05/2015 - 06/2004
6Bradykinin Receptors (Bradykinin Receptor)IBA
01/2015 - 12/2006
6Ondansetron (Zofran)FDA LinkGeneric
08/2013 - 05/2007
6Analgesics (Analgesic Drugs)IBA
01/2013 - 06/2007
6Capsaicin (Zostrix)FDA Link
07/2012 - 10/2003
6Tryptamines (Triptans)IBA
04/2012 - 10/2008
6Sodium Channels (Sodium Channel)IBA
05/2006 - 01/2002
5mu Opioid Receptors (mu Opioid Receptor)IBA
01/2016 - 06/2002
5Opioid Receptors (Opioid Receptor)IBA
10/2015 - 06/2004
5Sumatriptan (Imigran)FDA LinkGeneric
08/2013 - 10/2008
5Freund's AdjuvantIBA
06/2012 - 04/2005
5Ion Channels (Ion Channel)IBA
04/2012 - 06/2004
5Cholecystokinin (Pancreozymin)IBA
01/2012 - 01/2005
5Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
06/2011 - 01/2005
4dermorphin-saporinIBA
01/2016 - 06/2002
4Dopamine (Intropin)FDA LinkGeneric
10/2015 - 12/2012
4salicylhydroxamic acid (SHAM)IBA
10/2015 - 09/2003
4Serotonin (5 Hydroxytryptamine)IBA
06/2014 - 01/2012
4Cholecystokinin B ReceptorIBA
08/2013 - 01/2005
4Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
09/2012 - 08/2010
4CarrageenanIBA
08/2012 - 10/2003
4Substance PIBA
07/2012 - 08/2010
4Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
09/2011 - 08/2005
3saporinIBA
01/2016 - 05/2007
3Naproxen (Naprosyn)FDA LinkGeneric
08/2014 - 02/2009
3Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2014 - 04/2012
3Peroxynitrous Acid (Peroxynitrite)IBA
08/2012 - 06/2004
3L-Type Calcium Channels (Dihydropyridine Receptor)IBA
06/2012 - 09/2003
3Dizocilpine Maleate (Dizocilpine)IBA
06/2012 - 11/2002
33- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
04/2012 - 04/2005
3Opioid Peptides (Opioid Peptide)IBA
09/2011 - 02/2003
3dibutyldichlorotinIBA
11/2010 - 10/2008
3delta Opioid Receptors (delta Opioid Receptor)IBA
01/2008 - 02/2003
3CB2 Cannabinoid ReceptorIBA
10/2003 - 02/2003
2Diclofenac (SR 38)FDA LinkGeneric
10/2015 - 04/2012
2AdenosineFDA LinkGeneric
01/2015 - 02/2007
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2014 - 06/2004
2pregabalin (Lyrica)FDA Link
06/2013 - 07/2011
22- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
09/2012 - 04/2012
2Naloxone (Narcan)FDA LinkGeneric
08/2012 - 11/2007
2EnkephalinsIBA
08/2012 - 11/2007
23-nitrotyrosineIBA
08/2012 - 06/2004
2Formaldehyde (Formol)FDA Link
06/2012 - 02/2012
2Iodoacetates (Iodoacetate)IBA
04/2012 - 04/2011
2resiniferatoxinIBA
09/2011 - 01/2011
2Neuropeptide YIBA
09/2011 - 11/2002
2Calcium Channels (Calcium Channel)IBA
07/2011 - 04/2011
2Excitatory Amino AcidsIBA
06/2011 - 02/2004
2Neurotransmitter Agents (Neurotransmitter)IBA
06/2011 - 12/2005
2Interleukin-6 (Interleukin 6)IBA
05/2011 - 11/2010
2SodiumIBA
04/2011 - 10/2008
2TRPV1 receptorIBA
01/2011 - 03/2009
2p38 Mitogen-Activated Protein KinasesIBA
01/2011 - 07/2009
2SB 203580IBA
01/2011 - 07/2009
2Butyrates (Butyrate)IBA
10/2010 - 10/2008
2Carbon MonoxideIBA
08/2010 - 03/2009
2substance P-saporinIBA
02/2009 - 05/2007
2BradykininIBA
12/2008 - 12/2006
2Local AnestheticsIBA
05/2006 - 06/2004
2Sodium Channel Blockers (Potassium Sparing Diuretics)IBA
05/2006 - 01/2004
2N-Methylaspartate (NMDA)IBA
10/2005 - 06/2004
2Nerve Growth Factors (Neurotrophins)IBA
01/2005 - 06/2003
2Tetrodotoxin (Tetradotoxin)IBA
01/2004 - 01/2002
2AM 1241IBA
10/2003 - 09/2003
1compound 20IBA
09/2015
1Adenosine KinaseIBA
01/2015
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2015
1Adenosine A3 ReceptorIBA
01/2015
1Biological Markers (Surrogate Marker)IBA
08/2014
1gabapentin (Neurontin)FDA LinkGeneric
08/2014

Therapy/Procedure

26Ligation
08/2014 - 05/2002
7Therapeutics
01/2015 - 06/2003
6Spinal Injections
02/2014 - 06/2004
6Analgesia
01/2013 - 10/2006
4Oral Administration
09/2011 - 03/2009
2Drug Therapy (Chemotherapy)
08/2014 - 10/2005
2Axotomy
03/2014 - 07/2011
2Self Administration (Administration, Self)
04/2013 - 02/2007